![Sphere that has the top right fourth removed (exposed) Colors from left are orange, dark blue with orange dots, light blue with horizontal lines, then black. Inside the exposure is green and black with boxes.](/sites/default/files/styles/featured_square_large/public/2024-06/slicer.jpg?h=56311bf6&itok=bCZz09pJ)
Filter News
Area of Research
News Topics
- (-) Biomedical (28)
- (-) Cybersecurity (14)
- (-) Fossil Energy (4)
- (-) Transportation (27)
- 3-D Printing/Advanced Manufacturing (39)
- Advanced Reactors (8)
- Artificial Intelligence (46)
- Big Data (24)
- Bioenergy (51)
- Biology (59)
- Biotechnology (11)
- Buildings (19)
- Chemical Sciences (24)
- Clean Water (14)
- Climate Change (50)
- Composites (6)
- Computer Science (83)
- Coronavirus (17)
- Critical Materials (2)
- Decarbonization (46)
- Education (1)
- Emergency (2)
- Energy Storage (29)
- Environment (104)
- Exascale Computing (25)
- Frontier (24)
- Fusion (31)
- Grid (23)
- High-Performance Computing (44)
- Hydropower (5)
- Isotopes (27)
- ITER (2)
- Machine Learning (22)
- Materials (43)
- Materials Science (45)
- Mathematics (6)
- Mercury (7)
- Microelectronics (2)
- Microscopy (20)
- Molten Salt (1)
- Nanotechnology (16)
- National Security (36)
- Net Zero (8)
- Neutron Science (47)
- Nuclear Energy (55)
- Partnerships (16)
- Physics (28)
- Polymers (8)
- Quantum Computing (20)
- Quantum Science (30)
- Renewable Energy (1)
- Security (11)
- Simulation (31)
- Software (1)
- Space Exploration (12)
- Statistics (1)
- Summit (30)
- Sustainable Energy (44)
- Transformational Challenge Reactor (3)
Media Contacts
![Belinda Akpa applies her diverse expertise and high-performance computing to accelerate the drug discovery process and increase the chances of success when candidate molecules go to clinical trials. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-04/2021-P02772_1.jpg?h=0a8b6f8b&itok=seLu5znj)
Belinda Akpa is a chemical engineer with a talent for tackling big challenges and fostering inclusivity and diversity in the next generation of scientists.
![Heavy-duty vehicles contribute 23% of transportation emissions of greenhouse gases and account for almost one-quarter of the fuel consumed annually in the U.S. Credit: Chris Bair/Unsplash](/sites/default/files/styles/list_page_thumbnail/public/2021-04/highways_stock_0.jpg?h=1cbed347&itok=0cBMibFU)
Through a consortium of Department of Energy national laboratories, ORNL scientists are applying their expertise to provide solutions that enable the commercialization of emission-free hydrogen fuel cell technology for heavy-duty
![Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.](/sites/default/files/styles/list_page_thumbnail/public/2021-04/2021-P02194_small.jpg?h=c6980913&itok=bc6MRBX6)
Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.
![ATOM logo](/sites/default/files/styles/list_page_thumbnail/public/2021-03/ATOM_Logo_small.png?h=8f9cfe54&itok=Qpezfk8V)
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
![Oscar Martinez loads a special form capsule into the leak tester for a helium leak test in the packaging facility of the National Transportation Research Center. Credit: Jason Richards/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-12/2017-P00349_0.jpg?h=eeb3c961&itok=F9YI7AVU)
As program manager for the Department of Energy’s Oak Ridge National Laboratory’s Package Testing Program, Oscar Martinez enjoys finding and fixing technical issues.
![A Co-Optima research team led by Oak Ridge National Laboratory’s Jim Szybist in collaboration with Argonne, Sandia and the National Renewable Energy Laboratory, created a merit function tool that evaluates six fuel properties and their impact on engine performance, giving the scientific community a guide to quickly evaluate biofuels. Credit: ORNL/U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-12/2017-P08539-2_0.jpg?h=b6236d98&itok=h0OT2BqC)
As ORNL’s fuel properties technical lead for the U.S. Department of Energy’s Co-Optimization of Fuel and Engines, or Co-Optima, initiative, Jim Szybist has been on a quest for the past few years to identify the most significant indicators for predicting how a fuel will perform in engines designed for light-duty vehicles such as passenger cars and pickup trucks.
![ORNL researchers in advanced manufacturing, materials science and engineering collaborated to produce face shields and reusable mask molds so that industry can quickly mass produce. Credit: Carlos Jones/Oak Ridge National Laboratory, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-05/MDF_group_shot.jpg?h=5e9da067&itok=hx6y5O6o)
The University of Texas at San Antonio (UTSA) has formally launched the Cybersecurity Manufacturing Innovation Institute (CyManII), a $111 million public-private partnership.
![Frontier supercomputer](/sites/default/files/styles/list_page_thumbnail/public/2023-01/frontier_0.jpg?h=a1e1a043&itok=J3IM_Xeh)
A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.
![coronavirus](/sites/default/files/styles/list_page_thumbnail/public/2020-11/coronavirus_top10%20%28002%29.png?h=997b30da&itok=7I6TjG_l)
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
![Sandra Davern performs cell based assays to evaluate cell death and DNA damage in response to radiation in order to gain a better understanding of how radioisotope nanoparticles affect the human body.](/sites/default/files/styles/list_page_thumbnail/public/2020-10/2020-P15712.jpg?h=036a71b7&itok=6cpxN4v2)
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.